Omid Shah
Overview
Explore the profile of Omid Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thangjui S, Shah O, Zoltick J
Emerg Med J
. 2022 Mar;
39(4):324-336.
PMID: 35321924
No abstract available.
2.
Shah O, Tamaresis J, Kenyon L, Xu L, Zheng P, Gupta P, et al.
Biol Blood Marrow Transplant
. 2020 Feb;
26(6):1050-1070.
PMID: 32081787
A major cause of morbidity and mortality for patients who undergo hematologic stem cell transplantation (HSCT) is acute graft-versus-host disease (aGVHD), a mostly T cell-mediated disease. Examination of the T...
3.
Xu L, Durruthy-Durruthy R, Eastburn D, Pellegrino M, Shah O, Meyer E, et al.
Sci Rep
. 2019 Aug;
9(1):11119.
PMID: 31366893
Next-generation sequencing (NGS) is used to detect gene variants in genetically complex cell populations of cancer patient samples. Traditional bulk analysis can only provide average variant allele frequencies of the...
4.
Abid H, Watthanasuntorn K, Shah O, Gnanajothy R
Cureus
. 2019 Jun;
11(4):e4446.
PMID: 31245230
Metastatic brain tumors are the leading cause of central nervous system malignancies in adults, surpassing primary central nervous system with non-small cell lung cancer, accounting for more than 50% of...
5.
Narayan R, Benjamin J, Shah O, Tian L, Tate K, Armstrong R, et al.
Biol Blood Marrow Transplant
. 2019 Apr;
25(7):1293-1303.
PMID: 30951840
Non-myeloablative conditioning, such as with total lymphoid irradiation and antithymocyte globulin (TLI-ATG), has allowed allogeneic hematopoietic cell transplantation (allo-HCT) with curative potential for older patients and those with comorbid medical...
6.
Mathew N, Baumgartner F, Braun L, OSullivan D, Thomas S, Waterhouse M, et al.
Nat Med
. 2018 Apr;
24(4):526.
PMID: 29634689
This corrects the article DOI: 10.1038/nm.4484.
7.
Mathew N, Baumgartner F, Braun L, OSullivan D, Thomas S, Waterhouse M, et al.
Nat Med
. 2018 Feb;
24(3):282-291.
PMID: 29431743
Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) have...
8.
Baird J, Monjazeb A, Shah O, McGee H, Murphy W, Crittenden M, et al.
Int J Radiat Oncol Biol Phys
. 2017 Sep;
99(2):362-373.
PMID: 28871985
Novel ligands that target Toll-like receptors and other innate recognition pathways represent a potent strategy for modulating innate immunity to generate antitumor immunity. Although many of the current clinically successful...
9.
Tsermoulas G, Shah O, Wijesinghe H, Silva A, Ramalingam S, Belli A
World Neurosurg
. 2015 Nov;
88:569-575.
PMID: 26523763
Objective: In surgery for acute subdural hematoma (ASDH), the bone flap can be fixed onto the skull, left riding to provide partial skull decompression, or removed. This study assessed whether...